Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessPotassium Iodide pills see spike in price as Americans fear nuclear war...

Potassium Iodide pills see spike in price as Americans fear nuclear war with Russia

Add to Favorite
Added to Favorite

Large manufacturers of potassium iodide in the nation have seen stocks decreasing in weeks. This fall in inventory has taken place, late February, after Russia invaded Ukraine. Americans are reportedly afraid of a nuclear fallout. The Centers for Disease Control and Prevention (CDC) says that potassium iodide may be useful to combat radioactive iodine. However, it has health risks and indiscriminate use is not recommended.

The CDC says that potassium iodide, with the chemical formula KI, is a salt of stable iodine. It can block the absorption of radioactive iodine by the thyroid gland. This will protect the butterfly shaped gland in the throat from injury due to radiation. The CDC also mentions that this gland is “the most sensitive to radioactive iodine.”

However, the CDC also cautions that “people should only take KI (potassium iodide) on the advice of public health or emergency management officials.” The agency also says that extra doses do not offer extra protection and instead can “cause severe illness or death. The CDC also says that it doesn’t have much effect on those who are over forty.

The thyroid may be the least among the worries that would be expected, if there is an accidental nuclear explosion. Nuclear radiation can cause cancers and will contaminate the soil and water for several years.

Panic buying of diapers and other items took place during the pandemic and now as the Russia-Ukraine conflict continues there is a type of hoarding of potassium iodide pills and other items.

IOSAT, a pharmaceutical company which manufactures KI pills, said that its $14 packs are totally sold out. However, the same tablets are available on eBay for ten times or more than the original price. The company said that they would be restocking the pills after midMarch.

Earlier panic buying of KI tablets in 2011 resulted in Whole Foods erecting signs to warn people that taking extra pills was harmful. This panic buying trend was seen when there was an earthquake followed by a tsunami in Japan and its Fukushima nuclear power plant suffered damages as a result of these natural disasters.

Image  




Subscribe to get Latest News Updates

Latest News

You may like more
more

Advance Auto Parts Downgraded to Sell Amid Earnings Miss and Weak Outlook

CFRA analysts downgraded Advance Auto Parts (NYSE:AAP) from Hold...

Guggenheim Reiterates Buy Rating on Cabaletta Bio Amid Promising Data

Guggenheim analysts reaffirmed a Buy rating and a $23...

Goldman Sachs Initiates Neutral Coverage on Doximity, Highlights Balanced Growth Potential

Goldman Sachs analysts initiated coverage on Doximity (NYSE:DOCS) with...

JPMorgan Downgrades bluebird bio to Underweight Following Q3 Results

JPMorgan analysts downgraded bluebird bio (NASDAQ:BLUE) from Neutral to...